SpermFreeze Solution™, which is used for freeze storage of sperm, has obtained a CE mark and is thereby approved for sales within the European Economic Area (EEA).  

The freezing of sperm is used in connection with IVF treatment for patients who find it difficult to produce sperm samples or who are diagnosed as having cancer. In order to be able to become parents, these patients are completely dependent on the sperm surviving and functioning after freezing and thawing.
Vitrolife's SpermFreeze Solution™ has been developed to retain sperm DNA integrity and function after freeze storage, which has also been demonstrated in a clinical evaluation.

The CE mark means that SpermFreeze Solution™ complies with the demands made of this type of product in the EU's Medical Device Directive.

"An increased number of clinics today require a CE mark for products. Vitrolife has worked for and will continue to drive the question of the importance of CE marked products becoming a requirement in fertility treatment, with a view to increasing patient safety", says Magnus Nilsson, CEO.

SpermFreeze Solution™ will be launched as from February 2011.

January 12, 2011

Gothenburg

Magnus Nilsson

CEO